TI
UTHR icon

Tidal Investments’s United Therapeutics UTHR Stock Holding History

Tidal Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
34,012
+547
+2% +$308K 0.03% 487
2026
Q1 		$19.8M Buy
+33,465
New +$16.7M 0.04% 370
2025
Q4 		– Sell
-8,489
Closed -$3.56M – 2359
2025
Q3 		$3.56M Sell
8,489
-2,065
-20% -$694K 0.01% 681
2025
Q2 		$3.03M Sell
10,554
-950
-8% -$284K 0.02% 583
2025
Q1 		$3.55M Buy
11,504
+1,799
+19% +$617K 0.03% 488
2024
Q4 		$3.42M Sell
9,705
-1,567
-14% -$576K 0.03% 504
2024
Q3 		$4.04M Buy
11,272
+2,803
+33% +$947K 0.04% 374
2024
Q2 		$2.7M Buy
8,469
+200
+2% +$52.9K 0.04% 440
2024
Q1 		$1.95M Buy
8,269
+167
+2% +$37.7K 0.03% 540
2023
Q4 		$1.78M Buy
8,102
+716
+10% +$165K 0.04% 398
2023
Q3 		$1.67M Sell
7,386
-64
-0.9% -$14.7K 0.05% 368
2023
Q2 		$1.65M Sell
7,450
-6,185
-45% -$1.37M 0.05% 378
2023
Q1 		$3.05M Buy
13,635
+4,253
+45% +$1.05M 0.1% 194
2022
Q4 		$2.61M Buy
9,382
+854
+10% +$216K 0.1% 212
2022
Q3 		$1.79M Sell
8,528
-247
-3% -$55.2K 0.07% 242
2022
Q2 		$2.07M Sell
8,775
-3,505
-29% -$713K 0.08% 226
2022
Q1 		$2.2M Buy
12,280
+10,272
+512% +$1.96M 0.07% 232
2021
Q4 		$434K Sell
2,008
-5,392
-73% -$1.06M 0.01% 662
2021
Q3 		$1.37M Buy
7,400
+1,071
+17% +$211K 0.05% 242
2021
Q2 		$1.14M Buy
+6,329
New +$1.21M 0.04% 257

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Tidal Investments's UTHR Position: Q2 2026 in Review

Tidal Investments increased its United Therapeutics (UTHR) stake by 1.6% in Q2 2026, buying an estimated $308K and bringing the position to 34,012 shares worth $18.4M. The position accounts for 0.03% of the portfolio, ranked #487.

Tidal Investments first reported a position in UTHR in Q2 2021 and has held it in 20 quarters since. The position peaked at $19.8M in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Tidal Investments held 34,012 shares of United Therapeutics worth $18.4M as of Q2 2026.
  • Tidal Investments bought 547 United Therapeutics shares in Q2 2026, an estimated $308K.
  • United Therapeutics made up 0.03% of Tidal Investments's portfolio in Q2 2026, its #487 holding.
  • Tidal Investments first reported a position in United Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Tidal Investments's United Therapeutics position peaked at $19.8M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.